VASO Corp
VASO Corp is a U.S.-based healthcare and information technology company organized around three operating segments: healthcare IT and managed network services, professional sales services for healthcare capital equipment, and proprietary medical devices and software. Through subsidiaries including VasoTechnology, VasoHealthcare, and VasoMedical, the company serves healthcare providers in the United States and international markets.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueHealthcare IT, managed network technology, and related support services delivered through VasoTechnology.
Commission-based sales services for GE HealthCare capital equipment sold into provider markets.
Proprietary medical devices, ARCS SaaS, and associated service offerings sold by VasoMedical.
Products
Reported · share of revenue- Managed IT Systems and Services47.5 %
- Revenue Recognized Over Time43.5 %
- Software Sales and Support3.6 %
- Equipment Sales and Services2.7 %
- Medical Equipment Sales2.6 %
- Medical Equipment Service0.1 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
VASO sells primarily to healthcare providers, including hospitals, clinics, and the middle market of provider organizations that purchase imaging and diagnostic equipment. It also serves healthcare organizations that need IT infrastructure, network management, and software tools to support clinical and operational workflows. In the equipment segment, customers include domestic and international buyers of proprietary medical devices and ARCS software.
Buys GE HealthCare capital equipment through VasoHealthcare for imaging and diagnostic use.
Buys managed network and healthcare IT services to support clinical and operational systems.
Buys proprietary devices and ARCS SaaS for healthcare-related applications.
Buys equipment and software through VasoMedical's international operations, including China.
Strategy
VASO’s stated direction is to grow through internal expansion, new partnerships, and strategic investments focused on medical and IT service companies. The company’s multi-segment structure gives it flexibility to combine recurring healthcare IT services, equipment sales relationships, and proprietary device/software offerings. That mix can broaden customer reach while keeping the business tied to healthcare technology demand.
The company relies on its current operating platform to expand customer relationships and revenue.
External alliances can extend market access and add capabilities in healthcare and IT services.
Geography
2025VASO is headquartered in the United States and operates both domestic and international businesses through its subsidiaries. The company’s equipment segment includes U.S. operations and a separate international business, with China specifically referenced in recent disclosures. Geography matters because the business combines U.S.-based healthcare service demand with exposure to international equipment deliveries and software sales.
Risks
VASO faces execution risk across three different businesses, each with different demand drivers, customer cycles, and operating requirements. Its professional sales service segment depends on GE HealthCare equipment deliveries and acceptance timing, while the equipment segment has exposure to international demand, including China. Like other healthcare technology companies, it also faces regulatory, technology, and customer concentration risks tied to provider spending and product adoption.
Revenue is recognized only after equipment is accepted at the customer site, creating timing volatility.
Exposure: Professional sales service segment
The equipment segment includes international business and recent disclosures reference lower deliveries in China.
Exposure: Equipment segment
The professional sales service segment is tied to GE HealthCare product deliveries and commercial terms.
Exposure: GE HealthCare relationship
Healthcare IT and medical device offerings must keep pace with clinical, cybersecurity, and regulatory requirements.
Exposure: Healthcare IT and medical devices
Accounting
Judgemental itemsRevenue is recorded only after customer acceptance of equipment, affecting timing and deferred revenue.
Impact: Can materially shift revenue between quarters
Amounts billed before acceptance are recorded as deferred revenue, including a long-term portion.
Impact: Affects balance sheet liabilities and future revenue visibility
U.S. GAAP reporting requires estimates that can affect assets, liabilities, and expenses.
Impact: Can influence reported margins and period-to-period comparability
Similar listed companies
Publicly listed companies with a comparable business focus.
GE HealthCare Technologies Inc.
GEHC · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
VSee Health, Inc
VSEEW · Services-Health Services
Masimo Corp
Electromedical & Electrotherapeutic Apparatus
Masimo Corp develops and markets noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and remote monitoring devices for healthcare settings.
Akso Health Group
AHG · Services-Business Services, NEC
Akso Health Group is a U.S.-incorporated holding company with operating subsidiaries in the United States and China that sell medical devices and offer healthcare-related services.
Gaxos.ai Inc
GXAI · Services-Prepackaged Software
VisionSys AI Inc
VSA · Services-Educational Services
VisionSys AI Inc is a U.S.-listed Cayman Islands holding company focused on brain-machine interaction technologies and AI-enabled software and hardware systems.
Last updated: 29/04/2026